Skip to content

The effect of Foeniculum vulgare on postpartum blues

The effect of Foeniculum vulgare essential oil on postpartum blues in Primipara women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250723066603N1
Enrollment
90
Registered
2025-08-05
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Blues. Postpartum mood disturbance

Interventions

Intervention 1: Intervention group: People in the intervention group will receive fennel (Fennelin 30 mg) oral capsules manufactured by Barij Company. The use of fennel (Fennelin) capsules will be exp

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1- Having an active record in the SIB system or receiving prenatal care from a midwife/obstetrician. 2- Married women aged 18–49 years. 3- Minimum literacy (ability to read and write). 4-Iranian citizenship. 5- Residency in Hamadan city. 6- Primiparity (first childbirth experience). 7- Being a monogamous and first wife 8- delivery (gestational age 37–41 weeks, confirmed by first-trimester ultrasound).Singleton pregnancy. 9- Having a singleton pregnancy 10- SPBQ score >8 ( Stein Postpartum Blues Questionnaire) on the first postpartum day. 11- EPDS score <13 (Edinburgh Postnatal Depression Scale) on the first postpartum day. 12- DASS-21 subscale scores:Anxiety (0–14)Stress (0–25)(Less than "severe" severity) on the first postpartum day. 13-Planned pregnancy. 14- Newborn birth weight =2500 g. 15- Healthy infant (no congenital disorders or major medical conditions). 16- Having a home phone or a cell phone

Exclusion criteria

Exclusion criteria: 1- Prolonged/difficult labor (>20 hours in first/second stage, instrumental delivery, etc.) per medical records. 2- Exposure to traumatic/stressful events in the past 3 months (severe illness/death of first-degree relatives, accidents, job loss, etc.). 3-Maternal chronic medical conditions (hypertension, diabetes, epilepsy, renal/cardiac/pulmonary/gastrointestinal diseases, coagulopathies, etc.) per self-report/medical records. 4- Maternal history/current diagnosis of psychiatric disorders (bipolar disorder, depression, delirium, schizophrenia, PTSD, etc.) per self-report/medical records. 5- Family history of psychiatric disorders. 6-Physical/mental disability or chronic illness in spouse/children. 7-Maternal alcohol/drug abuse. 8-High-risk pregnancy (gestational diabetes, preeclampsia, eclampsia, bleeding/spotting during pregnancy, etc.) per self-report/medical records. 9-History of infertility. 10- Postpartum complications (hypertension, abnormal bleeding, breast complications, etc.) per self-report/medical records. 11- Allergy to fennel or Edible paraffin oil. 12-Non-compliance with capsule intake for =3 consecutive days. 13- Hospitalization of mother/neonate for any reason during the study. 14- Neonatal death. 15- Family conflicts during the study (impending divorce, domestic disputes, unemployment, spouse's addiction, etc.). 16- Diagnosed congenital anomalies/neonatal diseases during the study. 17- Use of relaxation techniques (yoga, massage, music therapy, acupuncture, homeopathy, reflexology) or pharmacological/herbal treatments (fennel, lavender, chamomile, rose, lemon balm, orange blossom, rosemary, thyme, etc.) for postpartum distress during the study. 18- Questionnaires with >10% unanswered items. 19- Allergy to carrots or celery.

Design outcomes

Primary

MeasureTime frame
Postpartum blues score from Stein's postpartum blues questionnaire. Timepoint: before the start of the intervention and 4?10, 14 days after the start of intervention. Method of measurement: Stein postpartum blues questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Pirdadeh Beiranvand

Khoram-Abad University of Medical Sciences

kimia_n72@gmail.com+98 66 1322 9095

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026